Introduction
============

Protein *S*-acylation is a lipid modification that involves the covalent attachment of long-chain fatty acids to thiol groups of cysteine (Cys) residues through thioester linkage. This type of protein modification is commonly referred to as *S*-palmitoylation (S-PALM) because Cys residues are predominately acylated with palmitic acid (16-C), although Cys may also be modified with both longer-chain fatty acids and unsaturated fatty acids ([@B135]; [@B122]). Cys *S*-fatty-acylation is a reversible posttranslational modification (PTM) that can dynamically regulate protein stability, trafficking, and activity ([@B3]; [@B139]). S-PALM is mediated by the aspartate-histidine-histidine-cysteine (DHHC) family of protein acyltransferases (PATs) and different classes of thioesterases ([@B62]; [@B20]; [@B35]; [@B40]; [@B34]) (**Figure [1](#F1){ref-type="fig"}**). The mechanisms that underlie site-selective S-PALM and the potential role of specific sequence motifs remain largely unknown. The large substrate diversity is related to the large array of PATs ([@B91]). Twenty-three distinct DHHC among PATs have been identified in mammalian cells, which mediate the bulk of protein palmitoylation ([@B91]; [@B92]). In contrast, the existence of depalmitoylating enzymes remains controversial. To date, seven proteins---ABHD17, ABHD12, ABHD13, Lypla1, Lypla2, Apt1, and Ppt1---have been identified as candidates for several limited substrates, such as H-Ras, PSD-95, and Gα ([@B73]; [@B140]; [@B132]). However, remaining unknown is whether these enzymes are able to depalmitoylate other *S*-palmitoylated substrates.

![Dynamic *S*-palmitoylation of proteins. *S*-Palmitoylation is a reversible and dynamic protein modification that is mediated by DHHC-palmitoyltransferases and acyl protein thioesterases that attach to and remove palmitate from cysteine residues of proteins, respectively.](fnmol-11-00175-g001){#F1}

The unique reversible nature of this PTM allows palmitoylated proteins for dynamic relocation between different cellular compartments ([@B34]; [@B53]; [@B118]). Owing to the palmitate hydrophobicity, modified proteins normally associate with the membranes of various organelles and facilitate trafficking between these organelles ([@B61]; [@B41]; [@B1]). Features of the palmitoylation domains that are important for membrane targeting include the spacing of palmitoylated cysteines and the presence of basic amino acids downstream of the cysteines ([@B105]). However, it is still unclear how these specific features of *S*-palmitoylation contribute to protein sorting.

The emerging picture is that palmitoylation may be crucial for directing proteins to distinct transport vesicles and allows a selection of specific cytosolic proteins to bind on secretory vesicles ([@B118]). Secretory vesicles have been found in both axons and dendrites of neurons and distribute modified proteins to all neuronal compartments ([@B70]). Proteins are packaged into distinct transport carriers and transported to the specific axonal or dendritic compartments ([@B22]). There, sorting signals, within the cytoplasmic region of transmembrane proteins, are recognized by sorting adaptors and next concentrate them in the appropriate vesicles ([@B18]; [@B118]). Various sorting motifs, such as tyrosine- or dileucine-based motifs, are present in the majority of proteins, and interact with different adaptor protein complexes ([@B10]; [@B121]; [@B93]). Interestingly, different substrate proteins can co-traffic on a single vesicle ([@B117]). The secretory vesicles which transport palmitoylated SCG10 and N-Ras proteins also contain other palmitoylated proteins such as the microtubule associated protein MAP6 ([@B117]).

It is still unclear whether palmitoylated proteins influence secretory vesicle fusion. On the other hand, the selective retention of proteins at the final destination depends on the local activity of depalmitoylating enzymes. In neurons, palmitoylated MAP6 is bound to secretory vesicles and transported to all neurites. However, neuronal polarization leads to MAP6 depalmitoylation, resulting in membrane release of MAP6 from vesicles and its accumulation in the newly formed axon ([@B117]).

Numerous studies have shown that neuronal proteins are modified by palmitoylation. Among these, we can distinguish scaffolding proteins, ion channels, signaling proteins, enzymes, cell adhesion molecules, and many G-protein-coupled receptors ([@B62]; [@B100]; [@B105]). Moreover, S-PALM is thought to be a particularly important regulator of synaptic plasticity, a biological process by which diverse neuronal activity modulates protein composition at the synapse, leading to changes in synaptic strength ([@B129]; [@B62]). Several S-PALM target synaptic proteins contribute to the dynamic and functional modulation of synapses ([@B129]; [@B62]; [@B91]; [@B35]; [@B139]; [@B34]). The purpose of this review is to demonstrate that the S-PALM-based regulation of synaptic proteins is not accidental, but highly defined to specific molecules and pathways that can be modified in neurological disorders. Thus we chose the major synaptic proteins with different molecular functions such as scaffolding proteins, receptors, kinases, and signaling molecules modulated by S-PALM. We also provide examples of neurological disorders in which the role of S-PALM has been confirmed. We then discuss the methods that are available for detecting and analyzing S-PALM, together with their advantages and disadvantages.

Palmitoylated Synaptic Proteins
===============================

PSD-95
------

As the most abundant scaffolding protein in the postsynaptic density (PSD) at excitatory synapses, PSD-95 is thought to be responsible for targeting and stabilizing various proteins, including glutamate receptors \[*N*-methyl-D-aspartate receptors (NMDARs) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)\], neuroligin, potassium channels, and other scaffolding proteins, to the postsynaptic membrane ([@B135]; [@B122]). Therefore, PSD-95 significantly contributes to neurotransmission and synaptic strength. PSD-95 is palmitoylated at two cysteine residues, Cys3 and Cys5 ([@B56]; [@B91]; [@B52]). The palmitoylation of this protein is essential for its clustering at the PSD and subsequent membrane scaffolding function ([@B58]) (**Figure [2A](#F2){ref-type="fig"}**). Notably, the palmitate turnover on PSD-95 is regulated by neuronal activity ([@B27]; [@B139]). The greater stimulation of glutamate receptors results in the depalmitoylation of PSD-95 and its dissociation from the PSD ([@B116]). This leads to the internalization of glutamate receptors and downregulation of synaptic strength. Lower neuronal activity induces the palmitoylation of PSD-95 and promotes the trafficking of PSD-95 and glutamate receptors to the postsynaptic membrane ([@B129]; [@B52]; [@B116]; [@B58]). PSD-95 has shown apparent palmitate cycling. This process is distinctively regulated by combination of palmitoylating and depalmitoylating enzymes in response to extracellular stimuli in neuros ([@B140]). Thus, the glutamate-induced palmitoylation cycle of PSD-95 is of key importance to synaptic strength and plasticity.

![Schematic overview of *S*-palmitoylated proteins that are crucial for excitatory synapse function. **(A)** PSD-95. Dendritically localized DHHC mediates activity-sensitive palmitoylation of PSD-95 and its synaptic clustering. Palmitoylated PSD-95 regulates glutamate receptors (NMDAR and AMPAR) recruitment at postsynaptic sites, thus affecting synaptic efficacy. Enhanced stimulation of glutamate receptors leads to depalmitoylation of PSD-95 and its dissociation from the PSD. As a result of PSD-95 depalmitoylation, the glutamate receptors internalize and the synapse strength decreases. **(B)** AMPAR. Palmitoylation of GluA1/A2 subunits on the *transmembrane domain (TMD) accumulates AMPAR in the Golgi apparatus, whereas depalmitoylation triggers receptor trafficking to the cell surface. C-terminal palmitoylation of GluA1/A2 does not influence the glutamate-dependent steady-state surface expression of AMPAR. On the other hand, palmitoylated form of the receptor is more sensitive to AMPA- and NMDA-induced receptor internalization. **(C)** NMDAR. Palmitoylation of the NMDARs on a membrane-proximal region of the NR2A/2B subunits ensures proper surface delivery and increases the stability of NMDAR on the postsynaptic membrane via tyrosine phosphorylation. In contrast, palmitoylation of the NR2A/2B subunits in the middle of C-terminal region increases accumulation of the NMDAR in the Golgi apparatus and decreases receptor surface expression. In turn, depalmitoylation of the NR2A/2B subunits regulates release of NMDA receptors from the Golgi for surface delivery.*](fnmol-11-00175-g002){#F2}

Glutamate Receptors
-------------------

Based on their pharmacological properties ionotropic glutamate receptors are divided into three classes of: α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors (AMPARs), NMDARs, and kainate receptors (KARs).

α-Amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors mediate the majority of fast excitatory synaptic transmission in the mammalian brain ([@B111]). The dynamic regulation of AMPARs at the synapse depends on interactions with PSD-95 and self-palmitoylation. AMPARs are ligand-gated ion channels that are composed of combinations of four separate subunits (GluA1-4) ([@B51]). Notably, the S-PALM of these receptors is a subunit-specific process that affects their localization and trafficking ([@B48]; [@B62]; [@B74]; [@B136]) (**Figure [2B](#F2){ref-type="fig"}**). Synaptic AMPARs predominantly comprise combinations of GluA1 and GluA2, which are directly regulated by S-PALM. Two palmitoylation sites of these subunits have been described. One site, cysteine 610, in the second transmembrane domain, is similar for both subunits, whereas the other site, on their C-terminal regions is different. GluA1 and GluA2 are palmitoylated at cysteine 811 and cysteine 836, respectively ([@B48]; [@B136]; [@B51]). Palmitoylation in the transmembrane domain causes accumulation of the receptor in the Golgi apparatus and inhibits its surface expression. On the other hand, palmitoylation of the C-terminal site does not affect the steady-state plasma membrane expression of the AMPAR. Interestingly, neuronal activity highly regulates the palmitoylation of GluA1 and GluA2. The blockade of neuronal activity increases the amount of palmitoylated GluA2 but not GluA1 in the postsynaptic membrane, whereas strong excitatory stimulation accelerates depalmitoylation but in a subunit-specific manner ([@B48]; [@B51]; [@B46]).

*N*-methyl-D-aspartate receptors are another type of glutamate receptor and ion channel that are found at most excitatory synapses ([@B107]; [@B135]). NMDARs consist of three families of homologous subunits: NR1, NR2, and NR3. The NMDAR NR2A and NR2B subunits are palmitoylated in their C-terminal region ([@B49]; [@B83]) (**Figure [2C](#F2){ref-type="fig"}**). Palmitoylation on a membrane-proximal region of NMDARs increases tyrosine phosphorylation, leading to enhanced stable surface expression of the receptor in neurons. In contrast, palmitoylation in the middle of the C-terminal region leads to the accumulation of NMDARs in the Golgi apparatus and decreases receptor surface expression ([@B49]). Similar to AMPARs, NMDAR palmitoylation is specific to a particular subunit and dynamically regulated in an activity-dependent manner. This PTM differentially modulates NMDAR localization and might be crucial for proper neuronal function.

Kainate receptors are engaged in the regulation of both excitatory and inhibitory neurotransmission. Similarly to AMPARs and NMDARs, KARs trafficking and plasma membrane expression are modulated by interactions with intracellular proteins. Five types of KAR subunits, GluK1, GluK2, GluK3, GluK4, and GluK5 can be arranged in different ways to form a tetramer, a four subunit receptor ([@B71]). GluK2 is palmitoylated at two C-terminal tail cysteine residues Cys858 and Cys871 ([@B21]). In contrast to AMPARs, palmitoylation of GluK2 promotes association of KARs with protein 4.1N and stabilizes neuronal surface expression of KARs due to reduced constitutive internalization of these receptors. Moreover, palmitoylation of Cys871 inhibits phosphorylation of GluK2 by protein kinase C (PKC) and thereby modulates KAR function.

Dopamine Receptors
------------------

Dopamine is acting as a modulator of variety of neuronal functions, such as cognition, emotion, and motor activity ([@B131]; [@B145]; [@B124]). It activates five dopamine receptors, D~1~ through D~5~, which are classified into two subtypes, D~1~-like (D~1~ and D~5~) and D~2~-like (D~2~, D~3~, and D~4~) dopamine receptors. Activation of D~1~-like receptors may lead to excitation or inhibition of the target neuron while the activation of D~2~-like receptors usually is linked with neuronal inhibition.

Among D~1~-like receptor subtypes only *S*-palmitoylation of D~1~ receptor (D~1~R) was experimentally identified ([@B59]). Palmitoylation may target D~1~R through selective endocytic pathways (clathrin or caveolar) ([@B66]). It was demonstrated that a depalmitoylated D~1~R is internalized faster than palmitoylated one. Thus, palmitoylation may be involved in directing the D~1~R to the slower caveolae-dependent endocytic route ([@B66]). Instead, the functional significance of the homologous cysteines in D~5~R has to be elucidated.

All D~2~-like dopamine receptors contain C-terminal conserved cysteines which serve as the sites of palmitoylation. Some *in vitro* studies with insect cells (Sf9) and mammalian cells (HEK293) have shown that the short (D~2S~) and long (D~2L~) isoforms of D~2~R are palmitoylated ([@B90]; [@B42]; [@B26]). Moreover, it was demonstrated that this modification affects the plasma membrane expression and stability of D~2L~. However, the opposite results were also reported showing that the short isoform of D~2~R (D~2S~) is not palmitoylated and that the inhibition of palmitoylation does not affect receptor functions, including surface expression ([@B145]). Other study has shown that D~3~R receptor is also *S*-palmitoylated. D~3~R palmitoylation was found to be required for the proper expression of this receptor on the cell surface, endocytosis, agonist binding, and receptor tolerance. Also third member of D~2~-like subtype of dopamine receptors, D~4~R, has been identified in *S*-palmitoylated form. Similarly to D~3~R, *S*-palmitoylation of D~4~R is required for its proper localization within the plasma membrane, endocytosis, and signaling ([@B144]).

GABA Receptors
--------------

A striking example of the neuronal palmitoyl regulation of inhibitory synapses is provided by γ-aminobutyric acid type A receptors (GABA~A~Rs) ([@B63]; [@B29]; [@B76]). These receptors are heteropentameric GABA-gated chloride channels that consist of subunits from seven homologous subclasses. The majority of these receptors contain α1--6, β1--3, and γ1--3 subunits. Of particular interest is the γ2 subunit, which is required for targeting GABA~A~Rs to inhibitory synapses ([@B76]). Notably, this subunit is *S*-palmitoylated on multiple cysteine residues in the cytoplasmic region, and this mechanism regulates the normal expression of GABA~A~Rs at the cell surface of neurons ([@B123]) (**Figure [3A](#F3){ref-type="fig"}**). Using the SOS recruitment-yeast two-hybrid system it was shown that the γ2 subunit of GABA~A~R is a substrate for the palmitoyltransferase, Golgi-specific DHHC zinc finger domain protein (GODZ) ([@B63]). Disrupting GODZ function or expression levels using dominant negative or RNAi approaches resulted in a significant reduction in the amplitude of mIPSCs attributed to a decrease in postsynaptic GABA~A~Rs number. Likewise, immunofluorescent analyses of neurons transfected with a GODZ-specific shRNA vectors revealed a marked reduction of punctate γ2 subunit immunoreactivity as well as loss of postsynaptic gephyrin staining compared with neurons transfected with control shRNA ([@B29]). From these studies it is evident that the S-PALM of GABA~A~Rs is implicated in the dynamic regulation of membrane localization and function of these receptors, thereby modulating GABAergic inhibitory transmission.

![Schematic overview of *S*-palmitoylated proteins that are crucial for inhibitory synapse function. **(A)** GABAR. Palmitoylation of the γ2 subunit determines the stability and mobility of receptors in the postsynaptic membrane and is required for normal GABAergic inhibitory transmission. **(B)** Gephyrin. Gephyrin, palmitoylated on two cysteine residues forms stable clusters at the postsynaptic membrane. Thereby increasing the strength of GABAergic transmission. Stimulation of GABAergic transmission leads to gephyrin palmitoylation and membrane association, ultimately increasing the size of gephyrin clusters.](fnmol-11-00175-g003){#F3}

Gephyrin
--------

Gephyrin is an inhibitory synapse scaffolding protein that anchors glycine and major subsets of GABA~A~Rs in the postsynaptic membrane ([@B17]). It was found to be palmitoylated at two cysteine residues (Cys212 and Cys284) that are critical for both the association and stable clustering of gephyrin at GABAergic synapses ([@B24]) (**Figure [3B](#F3){ref-type="fig"}**). Furthermore, gephyrin S-PALM is regulated by GABA~A~R activity. The activation of these receptors by agonists increases the palmitoylation of gephyrin and its membrane affinity, whereas the blockade of GABAergic transmission evokes opposite effects ([@B5]).

LIM Kinase-1
------------

The important actin regulatory protein LIM kinase-1 (LIMK1) phosphorylates and inactivates the actin-severing protein cofilin, thus promoting actin polymerization ([@B137]). LIMK1 appears to be particularly important for actin regulation in dendritic spines on which most excitatory synapses are formed ([@B55]). Changes in the size and shape of individual spines are closely associated with synaptic efficiency ([@B55]; [@B12]; [@B11]). Dynamic modulation of the actin cytoskeleton enables rapid changes in the shape or volume of dendritic spines in response to stimulation ([@B54]). This process requires the precise spatial regulation of proteins that increase actin polymerization. This mechanism was shown to consist of the palmitoylation of LIMK1 (**Figure [4A](#F4){ref-type="fig"}**). LIMK1 is palmitoylated at adjacent cysteine residues, Cys7 and Cys8, and this PTM is crucial for LIMK1 function because it not only controls the targeting of LIMK1 to spines but is also essential for the activation of LIMK1 by its membrane-localized upstream activator PAK ([@B37]). These results show that palmitoyl-LIMK1 is critical for normal spine actin turnover, activity-dependent structural plasticity, and long-term spine stability.

![Schematic overview of *S*-palmitoylated signaling molecules that are important for synapse function. **(A)** LIM kinase-1. Palmitoylation targets LIMK1 to the spine membrane, where it is phosphorylated by membrane-bound activators such as Cdc42/PAK. Palmitoylated LIMK1 phosphorylates cofilin and thus regulates spine-specific actin polymerization and morphological plasticity. In contrast, non-palmitoylated LIMK1 remains inactive **(B)** GTPase Cdc42. Palmitoylated Cdc42 accumulates in dendritic filopodia modulating their maturation and is strongly concentrated in dendritic spines. In response to enhanced neuronal activity Cdc42 is depalmitoylated and dissociated from the spine. **(C)** Tyrosine-protein Fyn kinase. Palmitoylation of Fyn is required for its membrane localization and thus proper action. Palmitoylated Fyn phosphorylates various substrates important for the accurate synaptic functioning, e.g., PSD-95, NMDAR, GABAR.](fnmol-11-00175-g004){#F4}

Cdc42
-----

The Rho family guanosine triphosphatase (GTPase) Cdc42 regulates cytoskeletal organization and membrane trafficking in such physiological processes as cell proliferation, motility, and polarity. Interestingly, Cdc42 is rapidly and locally activated in dendritic spine heads by potentiating stimuli, reflecting its unique contribution to the regulation of spine morphology ([@B133]). Cdc42 is expressed in the two splice variants: canonical (which is prenylated) and a brain-specific form (which can be palmitoylated). These two isoforms have distinct dendritic localizations. Cdc42-prenyl is distributed throughout the dendrite, at both the dendritic spine and shaft. Cdc42-palm is more heavily localized to dendritic spines. The Cdc42-palm isoform was shown to be required for the extension of dendritic filopodia, the key stage of spine formation and synaptogenesis ([@B62]) (**Figure [4B](#F4){ref-type="fig"}**). Interestingly, glutamate induces the depalmitoylation and rapid dislocation of Cdc42 from dendritic spines. Thus, the concentration of Cdc42 in spines can be rapidly modified by neuronal activity in a palmitoylation-dependent manner, which may provide dynamic changes in spine morphology ([@B130]; [@B86]).

Tyrosine-Protein Fyn Kinase
---------------------------

Several studies have indicated a role for palmitoylation in signaling by Src-family kinases ([@B108]) (**Figure [4C](#F4){ref-type="fig"}**). The influence of Fyn kinase on neuronal signaling has long been known. The importance of palmitoylation for Fyn membrane targeting suggests that neuronal Fyn function requires its palmitoylation-dependent synaptic membrane association ([@B39]). Notably, neuronal Fyn substrates include several transmembrane or membrane-associated proteins that are key components of excitatory synapses. One of the best-known neuronal Fyn substrates is the NR2B subunit of the NMDA-type glutamate receptor, and phosphorylation by Fyn has been proposed to stabilize this subunit at the neuronal cell surface ([@B119]). The synaptic scaffolding proteins PSD-95 and PSD-93 are also Fyn binding partners and substrates ([@B89]). Interestingly, the important role of Fyn in signaling is not limited to excitatory synapses because Fyn also likely phosphorylates GABA receptors that are localized to inhibitory synapses ([@B60]).

Palmitoylation and Neurological Diseases
========================================

Numerous studies have demonstrated that defects in protein palmitoylation and the aberrant activity of palmitoylating and depalmitoylating enzymes are associated with a wide range of human neurological diseases. In many cases, pathophysiology correlates with changes in the pattern of this modification at the specific protein target level of specific modified sites (**Figures [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}**).

![Schematic overview of *S*-palmitoylated proteins and DHHC enzymes related to neurodegenerative diseases. **(A)** Alzheimer's disease. S-PALM APP is enriched in lipid rafts where it is cleaved by BACE1. DHHC3/GODZ, DHHC4, DHHC7, and DHHC15 promote the S-PALM of BACE1, which may facilitate the amyloidogenic process. Additionally, DHHC12 is involved in the regulation of APP localization, trafficking, and metabolism. **(B)** Huntington's disease. The S-PALM of HTT is crucial for protein localization and trafficking. PolyQ expansion in HTT leads to lower affinity of the protein for its specific DHHC17, resulting in a reduction of HTT palmitoylation. Ion-resistant mutant HTT exhibited an increase in toxicity and a propensity to form aggregates.](fnmol-11-00175-g005){#F5}

![Schematic overview of *S*-palmitoylated proteins and DHHC enzymes related to neuropsychiatric diseases. **(A)** Schizophrenia. A reduction of the palmitoylation of many proteins, such as vesicular glutamate transporter 1 (VGLUT1), the small GTPase Ras, and myelin basic protein (MBP), has been observed in the dorsolateral prefrontal cortex of schizophrenia patients. DHHC8 is located in the microdeletion region of chromosome 22q11 and may increase the risk of schizophrenia. **(B)** Intellectual disability. DHHC15 and DHHC9 are implicated in X chromosome-linked ID (XLID). Genetic mutations of chromosome X led to the disruption of transcription of the *dhhc15* gene in a female patient with severe non-syndromic XLID. Four mutations of the *dhhc9* gene were identified in patients with XLID. **(C)** Major depressive disorder. The S-PALM of 5-HT receptors may be directly involved in receptor isomerization from an inactive to an active form and may represent a general feature that regulates constitutive receptor activity. S-PALM is a targeting signal that is responsible for the retention of 5-HT~1A~ receptors in lipid rafts, which represent scaffold platforms for receptor-mediated signaling.](fnmol-11-00175-g006){#F6}

Alzheimer's Disease
-------------------

Alzheimer's disease (AD) is one of the most common neurodegenerative disorders. The neurodegenerative process in AD is characterized by synaptic damage, accompanied by neuronal loss ([@B3]). Several lines of evidence support the notion that synaptic pathology and defective neurogenesis in AD are related to the progressive abnormal accumulation of amyloid β (Aβ) oligomers, together with the hyperphosphorylation of microtubule-associated protein tau ([@B125]). These toxic Aβ oligomers are derived from the sequential proteolytic processing of amyloid precursor protein (APP). This process involves several enzymes, including BACE1 ([β]{.ul}-site [A]{.ul}PP [c]{.ul}leaving [e]{.ul}nzyme) and β- and γ-secretases. [@B7], [@B8]) reported that two N-terminal cysteine residues of APP (Cys186 and Cys187) undergo S-PALM. S-PALM APP is enriched in membrane lipid rafts and forms dimers, leading to elevations of BACE1-mediated cleavage of the protein ([@B7]). These results indicate that APP palmitoylation enhances Aβ peptide production through the amyloidogenic pathway. A radiolabeling method, combined with point mutations of cysteines, showed that BACE1 is palmitoylated at four cysteine residues (Cys474, Cys478, Cys482, and Cys485). Although palmitoylated BACE1 is preferentially targeted to lipid rafts, this is not directly related to APP cleavage ([@B85]). Studies that used knock-in mice (with cysteine-to-alanine substitution at the palmitoylated sites) that selectively lacked BACE1 S-PALM reported that the palmitoylation-deficient mutant of BACE1 exhibited non-raft localization but no changes in the BACE1-dependent APP processing or secretion of Aβ ([@B2]). To date, the contribution of BACE1 S-PALM to Aβ production and AD progression is still unclear and requires further investigation.

The dysregulation of enzymes that control protein palmitoylation may also lead to the development of AD. DHHC12 has been shown to be involved in regulating APP localization, trafficking, and metabolism ([@B16]). Enzymatic activity inhibits APP metabolism, and the production of Aβ leads to retaining the APP protein in the Golgi apparatus, thus preventing trafficking to the trans-Golgi network and membrane. Five different DHHC enzymes--DHHC3/GODZ, DHHC4, DHHC7, DHHC15, and DHHC20--were shown to promote the palmitoylation of BACE1, which may facilitate the amyloidogenic processing of APP by targeting BACE1 to lipid rafts ([@B72]). This protective function of DHHC12 was hypothesized to be exerted by the palmitoylation of its substrates other than APP (**Figure [5A](#F5){ref-type="fig"}**).

Huntington's Disease
--------------------

The role of S-PALM in Huntington's disease (HD) is less well defined, but some research has shed light on the ways in which reversible palmitoylation may contribute to the pathogenesis of HD (**Figure [5B](#F5){ref-type="fig"}**). Huntington's disease is a neurodegenerative disease that is characterized by cognitive decline, motor dysfunction, and psychiatric disturbances ([@B141]; [@B127]; [@B106]). Huntington's disease is caused by a mutation of the *huntingtin* gene, resulting in an abnormal huntingtin protein (HTT) with a long polyglutamine, poly(Q) tail in the N-terminal region ([@B110]). At the histopathological level, the loss of medium spiny neurons and smaller striatal volume are observed. Huntingtin protein was shown to be highly expressed in neurons. Using the PULSE-CHASE radiolabeling method, a previous study found that HTT is palmitoylated at Cys214 under physiological conditions, which is crucial for protein localization and trafficking ([@B106]). PolyQ expansion in HTT was also shown to lead to lower affinity of the protein for its specific DHHC17, resulting in a reduction of HTT palmitoylation ([@B13]). Although palmitoylation-resistant mutant HTT exhibited an increase in toxicity and a propensity to form aggregates, palmitoylation may affect the pathogenesis of HD.

Schizophrenia
-------------

Schizophrenia is a chronic, severe psychiatric disorder that is often characterized by abnormal social behavior and prevalent cognitive deficits. Microdeletions in chromosome 22q11 have been described as a main factor that contributes to the development of neuropsychiatric symptoms of schizophrenia. The gene that encodes a palmitoylating enzyme, DHHC8, is located in the microdeletion region of chromosome 22q11 and may increase the risk of schizophrenia ([@B134]). Polymorphisms of the *dhhc8* gene have been reported to be associated with the risk of schizophrenia, but these associations appeared to depend on ethnicity ([@B75]; [@B30]). Therefore, the relationship between *dhhc8* gene polymorphisms and schizophrenia remains controversial ([@B87], [@B88]). Interestingly, other proteomic studies have reported a reduction of the palmitoylation of many proteins, such as vesicular glutamate transporter 1 (VGLUT1), the small GTPase Ras, and myelin basic protein (MBP), in the dorsolateral prefrontal cortex in schizophrenia patients ([@B98]) (**Figure [6A](#F6){ref-type="fig"}**).

Intellectual Disability
-----------------------

Intellectual disability is another neurodevelopmental disorder that is characterized by an early onset (\<18 years of age). S-PALM has been implicated in intellectual disability. Intellectual disability can be described as limitations in cognitive and adaptive function, such as daily living and social and communication skills. It was shown that palmitoylating enzymes, namely DHHC15 and DHHC9, are implicated in X chromosome-linked intellectual disability (XLID) ([@B101]; [@B114]; [@B57]). Genetic mutations of chromosome X were shown to lead to the disruption of transcription of the *dhhc15* gene in a female patient with severe non-syndromic XLID ([@B101]; [@B57]). Additionally, four mutations of the *dhhc9* gene were identified in four patients with XLID ([@B101]). These mutations affected the level of DHHC9 autopalmitoylation, thereby modulating the palmitoylation of its target proteins that may be involved in intellectual development ([@B84]) (**Figure [6B](#F6){ref-type="fig"}**). Therefore, it is extremely important to identify novel target proteins of DHHC9 that are associated with intellectual disability to facilitate molecular diagnosis and therapeutic treatment ([@B82]).

Major Depressive Disorder
-------------------------

Major depressive disorder (MDD) is a common psychiatric disorder that comprises a spectrum of symptoms, such as deficits in cognitive, psychomotor, and emotional processes ([@B103]; [@B6]). One class of *S*-palmitoylated proteins, serotonin \[5-hydroxytryptamine (5-HT)\] receptors, has been linked to MDD. Palmitoylation was experimentally confirmed for following 5-HT receptors: 5-HT~1A~, 5-HT~1B~, 5-HT~3A~, 5-HT~4~, and 5-HT~7~ ([@B94]; [@B99]; [@B102]; [@B65]; [@B68]; [@B38]).

5-HT~1A~ receptor is modified by covalently attached palmitate and that palmitoylation is irreversible and insensitive to agonist stimulation ([@B94]). Obtained data suggest that the S-PALM of 5-HT~1A~ receptors may be directly involved in receptor isomerization from an inactive form to an active form and may represent a general feature that regulates constitutive receptor activity ([@B102]; [@B38]) (**Figure [6C](#F6){ref-type="fig"}**). Furthermore 5-HT~1A~ receptor palmitoylation serves as a targeting signal responsible for localization of this receptor in membrane rafts. More importantly, the 5-HT~1A~ raft localization seems to be involved in receptor-mediated signaling. It was shown that palmitoylation of 5-HT~1A~ receptor is necessary for G~αi~-protein coupling and effector signaling where communication between receptors and G~αi~-subunits was completely abolished after blocking of this modification ([@B94]). Additionally, non-palmitoylated mutants of 5-HT~1A~ couldn't inhibit cAMP formation, indicating that palmitoylation of the 5-HT~1A~ receptor is critical for the enabling of Gi-protein coupling/effector signaling. Dysregulation of the serotonergic system has been observed in the brains of MDD patients and rodent models of depression and anxiety ([@B45]). The effect of 5-HT receptor S-PALM on structural plasticity that underlies depression remains to be elucidated.

Methods for Detecting S-Palm
============================

Despite accumulating evidence of the key role of S-PALM in physiological neuronal regulation and neuropathological processes, technical difficulties have hindered the detection and analysis of S-PALM. Such difficulties are further exacerbated by the lack of identification of an S-PALM consensus motif for prediction. The range of involvement of this PTM in synaptic plasticity appears to be underestimated. Therefore, determining the precise levels and sites of protein S-PALM is crucial for understanding the ways in which this dynamic lipid modification is regulated during neuronal activity.

Below we critically review the methods that are currently used to detect and enrich protein S-PALM. These methods can generally be divided into two major groups. The first group includes metabolic labeling methods that exploit synthetic analogs of fatty acids with biorthogonal handles (so-called chemical reporters) that are incorporated into proteins to Cys residues. The second group contains Acyl Biotin Exchange (ABE), Acyl Resin-Assisted Capture (Acyl-RAC), and Acyl-PEG Exchange (APE). All of these methods are based on selective thioester liberation and *S*-acylated residue labeling and thus have the potential to capture the full *S*-acyl proteome but not a specific fatty acid, such as palmitate. The methods that are used as chemical reporters can be applied to label proteins with fast fatty-acid turnover ([@B20]).

Metabolic Labeling
==================

Metabolic Radioactive Labeling
------------------------------

This is one of the most commonly used S-PALM detection methods. The oldest approach was radioactive labeling, first introduced by [@B109]. In the standard experiment, cells are transfected with a plasmid or viral vectors for specific protein overexpression and subsequently incubated with radioactive ^14^C- or ^3^H-labeled fatty acids, such as palmitate. \[^3^H\]Palmitate is intracellularly converted to fatty-acyl-CoA and then incorporated into proteins. The degree of \[^3^H\]palmitate integration is then visualized by autoradiography ([@B9]; [@B78]). However, such a procedure causes all endogenous proteins that undergo palmitoylation to incorporate the radiolabeled palmitate. Therefore, optimal labeling can only be achieved if the rate of synthesis and speed of palmitoylation turnover for the protein of interest are taken into account ([@B120]). In the final step, labeled proteins are enriched and analyzed using sodium dodecyl sulfate-polyacrylamide gel electrophoresis, exposed to X-ray films, and detected by fluorography.

In addition to detecting palmitoylation, radiolabeling is also utilized to monitor S-PALM turnover *in vitro*. The PULSE-CHASE labeling method has been successfully applied for decades. This method allows determination of the half-lives of the S-PALM of various proteins, including ankyrin ([@B113]), Gαi ([@B23]), α2A-adrenergic receptors ([@B64]), HTT ([@B106]), BACE1 ([@B8]), H-Ras ([@B4]), and N-Ras ([@B77]). In this approach, cells are exposed to radioactively labeled palmitate for a short period of time (i.e., the PULSE phase), followed by a phase in which cells are incubated with unlabeled (non-radioactive) palmitate (i.e., the CHASE phase). During S-PALM turnover, proteins lose the radioactive palmitate, and a gradual decrease in the radioactive signal is observed. Although it is a very sensitive and effective method for the absolute quantification of protein palmitoylation, it has several limitations. Notably, special care is needed when handling radioactive materials. The procedure is also hazardous and time-consuming, requiring several weeks to months for autoradiography exposure. Finally, this method requires high levels of isotopically labeled fatty acid. The major limitation is that this approach can be utilized only for a single protein that is predicted to be palmitoylated. Furthermore, S-PALM stoichiometry (i.e., the ratio of palmitoylated protein and its unpalmitoylated form) cannot be determined. The determination of palmitoylation sites is possible but only in combination with mutations of predicted sites or in combination with limited enzymatic digestion and specific antibodies that target regions of interest. Radiolabeling has been replaced by other much more sensitive techniques.

Metabolic Non-radioactive Labeling
----------------------------------

An alternative to the radiolabeling approach utilizes metabolic labeling combined with click chemistry. This method was introduced by ([@B80] and showed great promise in the large-scale profiling of protein palmitoylation. The metabolic method involves labeling cells with a biorthogonal alkyne tag- or azide tag-containing analog of palmitic acid ([@B25]; [@B104]; [@B62]). Different chemical reporters can be used in this process, such as Alk-16 or 17-ODYA ([@B14],[@B15]; [@B47]), HDYOA ([@B142]), Alk-14 ([@B67]), Az-15 ([@B14],[@B15]), and Az-14-CoA ([@B67]). Chemical reporters and natural fatty acids (fatty acyl-CoA) have similar sizes and structures, thus allowing their recognition by cellular acyltransferases. Palmitic acid derivatives that are incorporated into proteins that comprise the azide/alkyne moiety are subsequently conjugated to reporter molecules, mainly fluorophores or biotin derivatives.

The method that was introduced by [@B80] utilizes the commercially available alkyne fatty acid analog 17-octadecynoic acid (17-ODYA) and click chemistry ([@B15]). In the first step, 17-ODYA is fed into cells and actively incorporated into proteins that undergo palmitoylation. Next, 17-ODYA alkyne groups of modified proteins are conjugated with an azide-tagged reporter using a Cu(I)-catalyzed azide-alkyne cyclo addition reaction (CuAAC, click chemistry). The type of chemical reporter strictly depends on the downstream analysis. Generally, biotin or fluorescent rhodamine is used as a reporter molecule for the enrichment and detection of palmitoylated proteins using both mass spectrometry (MS) and other methods. The fluorescent reporters allow the robust in-gel visualization of S-PALM proteins, whereas the biotin-azide reporter is commonly used for streptavidin enrichment or Western blot. However, the visualization of palmitoylated proteins with the latter requires additional steps, such as transfer to a membrane and subsequent detection. However, both of them can lead to problems. Transfer efficiency can vary dramatically among proteins, depending on the ability of a protein to migrate out of the gel and its propensity to bind to the membrane. Additionally, immunodetection can generate a non-specific background. Importantly, however, this type of analysis can highlight endogenously biotinylated proteins. Currently, the biotin-azide reporter is mainly used for the enrichment of palmitoylated proteins and MS ([@B14]; [@B80]; [@B142]).

Metabolic labeling with 17-ODYA and click chemistry coupled with MS allows the global profiling of palmitoylated proteins. Using this approach, over 300 S-PALM proteins have been identified in Jurkat T-cells, including SNAP23, RAP2B, calnexin, GNAQ, and flotillin 1. Similar to radiolabeling, the dynamics of palmitoylation turnover can be monitored with PULSE-CHASE analysis by fatty acid analogs ([@B143]; [@B81]; [@B79]).

Differences in global palmitoyl dynamics under various conditions can be described by combining with the stable isotope labeling with amino acids in cell culture (SILAC) technique. In the standard SILAC approach, cells that express the tagged bait protein are fed with growth medium that contains the light isotope, and control cells are metabolically labeled with the heavy isotope or inversely ([@B128]). After metabolic labeling and cell lysis, equal amounts of light and heavy isotope-marked cell lysates are mixed and then purified using biotin-avidin affinity chromatography, followed by trypsin digestion and MS. Further analysis relies on measuring the ratio of light to heavy isotope-labeled forms for peptide pairs. Thus, comparisons of mass spectral peak intensities of peptide pairs allow the calculation of their relative abundance ratio, which is the basis for distinguishing specific proteins from non-specific background ([@B128]; [@B95]; [@B115]). Metabolic labeling coupled with SILAC enables the identification of fatty-acylated proteins with high confidence by evaluating the signal-to-background ratio and comparisons of protein acylation levels. Using this approach, the stimulation of glutamate receptors was shown to accelerate palmitoylation turnover ([@B35]). Among the identified palmitoylated proteins that undergo dynamic palmitoylation are Ras-family GTPases, G proteins, membrane-associated guanylate kinase (MAGUK) proteins, and leucine-rich repeat and PDZ domain (LAP) proteins. Thus, this method allows the determination of context-dependent changes in protein S-PALM that are induced by specific cellular signaling pathways. Unfortunately, this approach cannot be used to study palmitoylation in large organisms. Moreover, 17-ODYA is a known potent cytochrome P450 hydroxylase inhibitor that plays an important role in the metabolism of fatty acids. However, its effect on palmitoyl metabolism in living systems is still unclear. Similar to radiolabeling, the relative quantification of protein palmitoylation remains challenging because unpalmitoylated proteins are not visible. This method is based on the metabolic labeling of cells with exogenous fatty acid analogs, and other fatty-acylated proteins (e.g., *N-*myristoylated proteins, *N*^𝜀^-myristoylated proteins, and GPI-anchored modified proteins) are also labeled ([@B95]). Additionally, care must be taken at each step of this approach to minimize the loss of palmitoyl groups.

Click Chemistry-Proximity Ligation Assay
----------------------------------------

An extremely useful modification of the click chemistry method was its coupling with the proximity ligation assay (PLA). The latter was developed and first described by [@B33]. The PLA is a relatively simple technique that is based on an immunocytochemical reaction that utilizes one pair of oligonucleotide-coupled antibodies that bind in close proximity (\<40 nm) to different epitopes of protein or two interacting proteins. Following enzyme-mediated ligation of the added oligonucleotides, the obtained DNA circle is amplified, and the signal is then developed using fluorescently labeled oligonucleotides that are complementary to the replicated DNA. For many years, the PLA has been widely used for advanced and precise protein analysis ([@B43]; [@B112]). The principle of the click chemistry-PLA method has been reported ([@B36]). The authors showed that this approach can be successfully used to visualize cellular protein palmitoylation at the single protein level. In addition to imaging a specific palmitoylated cellular protein, this method can be applied to investigate the localization of this S-PALM protein using subcellular organelle markers. However, some limitations of this method should be considered. For example, it can only be used with fixed samples because of the toxicity of copper reagents that are needed for the click reaction. Another problem involves the fixation of cells with methanol because this causes the denaturation of many reporter proteins, such as green fluorescent protein (GFP) and red fluorescent protein (RFP). Therefore, this assay cannot be applied to cells that are transfected with plasmids that encode these proteins. Additionally, it is not always appropriate to use azide-tagged biotin to conjugate alkynyl palmitic acid because some tissues are characterized by high levels of endogenous biotin that can generate non-specific signals. To date, however, it is the only known method for the single-cell *in situ* imaging of S-PALM.

Metabolic labeling methods allow more sensitive and immediate detection compared with radioactive methods, and they are very useful for S-PALM protein determination and visualization in cell culture and cell lines. However, it is potentially difficult to apply these protocols to investigate protein *S*-acylation in tissue or cancer cells in which affected fatty-acid metabolism dramatically decreases the intake of exogenous long-chain fatty acids. Moreover, labeling methods require the application of modified palmitate acid analogs and prefer more stable S-PALM proteins than those with rapid palmitate turnover. The main steps of some of these metabolic labeling methods are shown in **Figure [7](#F7){ref-type="fig"}**.

![Schematic representation of the metabolic labeling workflow. S-PALM proteins can be studied using biorthogonal reactions. The cells are first incubated with palmitate derivatives (e.g., Alk-C16 and 17-ODYA; metabolic incorporation). Fixed and permeabilized cells are then processed for CuAAC (click chemistry) with either a fluorophore or affinity (biotin) tag. At this step, total S-PALM can be visualized by microscopy. Otherwise, after cell lysis, the level of S-PALM can be evaluated by in-gel fluorescence, Western blot (WB), or mass spectrometry (MS). For the single-cell *in situ* imaging of S-PALM in target protein, cells are subjected to the proximity ligation assay (PLA) using specific antibodies.](fnmol-11-00175-g007){#F7}

Biochemical Tools
=================

Biochemical approaches to palmitoylation analysis do not require metabolic labeling; instead, they take advantage of specific cleavage of the *S*-palmitoyl group by hydroxylamine. [@B25] described a novel method that utilizes a radioactive alkylation reagent to introduce the palmitoyl group by chemical reactions *in vitro*. In this procedure, free thiol groups are first blocked with N-ethylmaleimide (NEM). Palmitoyl thioester linkages are then selectively liberated by hydroxylamine, and then newly exposed cysteinyl thiols are captured via \[^3^H\]N-ethylmaleimide. Labeled in this way, protein moieties are detected by autoradiography. Using this approach, The authors described the palmitoylation of three proteins that mediate proper functioning of the nervous system, namely 5-HT~3A~, SNAP-25, and PSD-95. They also showed that their method was much more sensitive than traditional metabolic labeling methods that utilize titrated palmitate. They also confirmed that this protocol can be applied to the analysis of *S*-acylated proteins in native cells, tissues, and biofluids. A simplified comparison of all of these described biochemical methods are shown in **Figure [8](#F8){ref-type="fig"}**.

![Schematic overview of biochemical assays for S-PALM identification. **(A)** Acyl Biotin Exchange (ABE). **(B)** Palmitoyl Protein Identification and Site Characterization (PalmPISC). **(C)** Resin Assisted Capture (AcylRAC). **(D)** Acyl-PEG Exchange (APE). The upper panel shows the particular stages of each assay. TCEP, Tris(2-carboxyethyl)phosphine; NEM, N-ethylmaleimide; IAM, iodoacetamide; MMTS, methyl methanethiosulfonate; mPEG-Mal, methoxy-PEG-maleimide; Biotin-HPDP, *N*-\[6-(biotinamido)hexyl\]-3′-(2′-pyridyldithio)propionamide; MS/MS, tandem mass spectrometry.](fnmol-11-00175-g008){#F8}

Acyl-Biotinyl Exchange Assay
----------------------------

[@B104] based on the method of [@B25], developed acyl-biotinyl exchange (ABE) chemistry and applied it to the detection of protein palmitoylation on a proteomic scale ([@B126]) (**Figure [8A](#F8){ref-type="fig"}**). This approach also involved blocking all free cysteine thiols with NEM and the specific removal of thioester-linked palmitoyl groups by hydroxylamine-induced hydrolysis. However, in the third step, non-radioactive labeling of the newly formed thiols with sulfhydryl-reactive biotin (biotin-HPDP) was used. The lack of specific palmitoyl antibodies in the past significantly limited studies of protein palmitoylation. Currently, the biotinylation of hydroxylamine-released thiol groups allows Western blot detection using streptavidin-horseradish peroxidase or the enrichment of biotinylated proteins with streptavidin resin for subsequent MS. In a standard control procedure, thioester-containing proteins are distinguished from non-specifically enriched proteins by comparing samples that are treated in parallel with and without hydroxylamine ([@B104]; [@B62]). The enriched protein fraction is analyzed using label-free MS. The application of this method to the yeast *Saccharomyces cerevisiae* protein fraction allowed the identification of 12 known and 35 novel palmitoylated proteins. This was the first demonstration of the large-scale profiling of protein palmitoylation (palmitoyl proteomics). The ABE protocol was further extended by [@B62] to study *S*-acylated proteins from purified rat synaptosomes, embryonic rat neurons, and whole rat brain in three chemical steps. They identified 66 previously known neuronal palmitoyl proteins and more than 200 new *S*-palmitoylated candidates. The list of identified S-PALM proteins includes the scaffolding protein AKAP79/150, various ion channels, voltage-gated Na channels, and multiple transporters for neurotransmitter reuptake. [@B50] showed that the ABE method can also be easily combined with isobaric tagging for the relative and absolute quantification (iTRAQ) method, which allows the quantitative analysis of modified proteins. Using this approach, they identified more than 580 S-PALM proteins from *Arabidopsis thaliana*. The ABE method was also applied to differentially analyzed changes in the S-PALM of proteins in postmortem brains of schizophrenia patients. They identified 219 palmitoylated proteins in human frontal cortex and observed a significant reduction of the palmitoylation of 17 proteins.

In the context of synaptic physiology, the ABE method was mainly used in combination with Western blot to detect single protein targets of S-PALM. Using this type of analysis, the S-PALM of important synaptic proteins was identified, such as LIM kinase, AMPA, and the NMDA NR2A and NR2B receptor subunits ([@B108]; [@B116]). This method was also applied to detect APP protein in a model of AD. [@B7] used two independent methods, metabolic labeling with Alk-16 and ABE, and found that two N-terminal cysteine residues of APP undergo S-PALM.

The advantage of the ABE approach is palmitoyl protein enrichment from complex samples through the specific binding of biotin to avidin-resin, followed by release of the protein from beads by the simple reduction of disulfide bonds. Both single targeted protein and total protein extracts can be analyzed using liquid chromatograph (LC)-MS. Thus, ABE allows the identification of protein S-PALM targets but does not provide information about the exact site of S-PALM.

Palmitoyl Protein Identification and Site Characterization
----------------------------------------------------------

A partial solution to the aforementioned problem was the development of the Palmitoyl Protein Identification and Site Characterization (PalmPISC) technique ([@B138]) (**Figure [8B](#F8){ref-type="fig"}**). Similar to ABE, PalmPISC involves the selective exchange of an S-PALM Cys residue to biotinylated cysteine. PalmPISC also involves the trypsin digestion of all proteins prior to avidin affinity chromatography. This approach leads to the enrichment of only biotinylated peptides that are originally palmitoylated. After disulfide bond reduction, these peptides are released from the affinity column and analyzed by MS. PalmPISC allows pinpointing S-PALM proteins and precise sites of S-PALM modification. This method has been successfully used to analyze palmitoylation in tumor cell lines. It was also able to identify 67 known and 331 novel S-PALM proteins, including AP2A2, ADAM10, AP2, and Ahnak, and precisely determine 25 known and 143 new S-PALM sites.

A variant of the PalmPISC technique was published, with minor changes in cysteine labeling ([@B19]). This method, called site-specific Acyl Biotin Exchange (ssABE), also relies on selectively switching the S-PALM Cys residue to biotinylated Cys. In the first step, free Cys thiols are blocked with iodoacetamide (IAA) instead of NEM, which is normally used in PalmPISC. The S-PALM Cys residues are then converted to biotin, and only the previously modified peptides are purified using streptavidin resin. Eluted peptides that contain free Cys are further analyzed by MS. Using this method, The authors identified 906 palmitoylation sites on 641 proteins from mouse forebrain homogenates. Notably, however, The authors did not explain the lack of use of a blocking agent, which may lead to false positives.

Resin-Assisted Capture of *S*-Acylated Proteins
-----------------------------------------------

A simple alternative to ABE is the detection of *S*-acylated proteins by resin-assisted capture (Acyl-RAC) at the biotinylation site ([@B32], [@B31]) (**Figure [8C](#F8){ref-type="fig"}**). The Acyl-RAC method was initially applied to identify *S*-nitrosylation (SNO) sites in proteins. This assay is chemically analogous to the ABE method, but it replaces the biotin enrichment steps with direct conjugation with resin that contains thiol-reactive thiopyridine groups, which simplifies purification ([@B146]). This method can be easily adapted to investigate other reversible cysteine modifications, such as *S*-glutathionylation (SSG), disulphide formation, and SNO, which differ in reducing agents (e.g., glutaredoxin, dithiothreitol, ascorbate, and hydroxylamine) ([@B44]). Similar to ABE, Acyl-RAC coupled with LC-MS/MS and isobaric labeling with iTRAQ reporter tags allowed the identification of new *S*-acylated substrates, such as the β-subunit of the protein translocating system (Sec61b). Acyl-RAC was applied by [@B31] to the *S*-acylation detection of endogenous and overexpressed H-Ras in a mammalian cell system. The specificity of this assay was demonstrated with C181/184S double mutants, which cannot be *S*-acylated and were not detected with the Acyl-RAC method.

Acyl-PEG Exchange
-----------------

New mass-shift labeling method, APE, was developed by [@B96], [@B97]) (**Figure [8D](#F8){ref-type="fig"}**). This approach utilizes the hydroxylamine-sensitivity of thioesters and selective reactivity of Cys residues for site-specific alkylation with maleimide-functionalized polyethylene glycol reagents. APE induces a mass-shift on *S*-acylated proteins that can be directly verified by the Western blot analysis of target proteins with omitting the metabolic labeling or affinity enrichment of proteins ([@B96]). The authors tested this new method with several cell lines (HEK293T, NIH 3T3, and HeLa). They demonstrated the possibility of its application. They first showed that the endogenous interferon-induced transmembrane protein 3 (IFITM3), an important immune effector, is *S*-acylated, and its antiviral activity was directly correlated with the level of site-specific modifications of highly conserved Cys residues ([@B96], [@B97]). Therefore, an important feature of the APE assay is its ability to disclose the ratio of *S*-acylated vs. unmodified proteins of multiple sites of *S*-fatty acylation, which is crucial for understanding the ways in which quantitative differences in the levels of *S*-acylation control protein function and associated cellular phenotypes. Although APE allows the characterization of relative levels of *S*-fatty acylated proteins and their isoforms, it does not reveal whether specific proteins are directly *S*-acylated or the dynamics of modifications at specific sites.

All of the aforementioned methods, despite the many advantages of protein palmitoylation analysis, have several limitations. They generally require multiple reactions and the purification of samples by triplicate precipitation between each reaction step, which can cause substantial sample loss. Moreover, the incomplete blockade of free Cys residues can result in false positives. False negatives can also occur because of insufficient thioester hydrolysis by hydroxylamine, inefficient biotin labeling (for ABE, APE, and PalmPISC), or undefined enrichment using various resins.

A summary of the main advantages and disadvantages of the aforementioned methods is presented in **Table [1](#T1){ref-type="table"}**.

###### 

Advantages and disadvantages of *S*-palmitoylation detection and identification methods.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  METHOD                                                         ADVANTAGES                                                                          DISADVANTAGES                                                                                                         EXAMPLES OF IDENTIFIED PROTEINS                                                                                                              REFERENCE
  -------------------------------------------------------------- ----------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------
  ***METABOLIC LABELING***                                                                                                                                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                        

  *Metabolic radioactive labeling*                               • Sensitive and effective\                                                          • Can be utilized only for a single protein\                                                                          Ankyrin, Gαi, α2A-adrenergic receptor, H-Ras, N-Ras, p21N-ras BACE1, HTT, GluK2, 5-HT~1A~, D~1~R, 5-HT~1B~, 5-HT~3A~, 5-HT~4~, and 5-HT~7~   [@B109]; [@B77]; [@B113]; [@B23]; [@B64]; [@B9]; [@B78]; [@B59]; [@B4]; [@B94]; [@B69], [@B68]; [@B99]; [@B102]; [@B120]; [@B21]
                                                                 • Allows monitoring S-PALM turnover                                                 • The S-PALM/unpalmitoylated protein ratio cannot be determined\                                                                                                                                                                                                   
                                                                                                                                                     • Does not provide information on the exact site of S-PALM\                                                                                                                                                                                                        
                                                                                                                                                     •Radioactive\                                                                                                                                                                                                                                                      
                                                                                                                                                     • Hazardous and time-consuming                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                        

  *Metabolic non-radioactive labeling*                           • Allows robust in-gel visualization\                                               • Highlights endogenously biotinylated proteins\                                                                      APP, SNAP23, RAP2B, calnexin, D~2~R GNAQ, and flotillin 1                                                                                    [@B25]; [@B104]; [@B14],[@B15]; [@B47]; [@B80]; [@B35]; [@B142]; [@B26]
                                                                 • Allows global profiling of S-PALM proteins\                                       • Cannot be used to study palmitoylation in higher organisms\                                                                                                                                                                                                      
                                                                 • Allows monitoring S-PALM turnover                                                 •Only *in vitro* studies\                                                                                                                                                                                                                                          
                                                                                                                                                     • Non-specific (other fatty-acylated proteins are labeled)\                                                                                                                                                                                                        
                                                                                                                                                     • Does not provide information on the exact site of *S*-palmitoylation                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                        

  *Click chemistry-proximity ligation assay*                     • Allows visualization of single S-PALM protein\                                    •Can only be used on fixed samples\                                                                                   Wnt, Sonic Hedgehog, H-Ras,                                                                                                                  [@B36]
                                                                 • Provides information on S-PALM protein subcellular localization\                  • Cannot be applied to cells that are transfected with plasmids that encode tagging proteins (e.g., GFP)\                                                                                                                                                          
                                                                 • Can be used to investigate colocalization of S-PALM protein with other proteins   • Can generate non-specific signals from endogenous biotin\                                                                                                                                                                                                        
                                                                                                                                                     • Does not provide information on the exact site of S-PALM                                                                                                                                                                                                         

                                                                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                        

  ***BIOCHEMICAL TOOLS***                                                                                                                                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                        

  *Acyl-biotin exchange assay*                                   • Provides large-scale profiling of protein S-PALM\                                 • Does not provide information on the exact site of S-PALM\                                                           LIM kinase, AMPA, NMDA NR2A and NR2B receptor subunits, 5HT~3A~, SNAP-25, PSD-95, APP, VGLUT1, small GTPase Ras, MBP, D~3~R, D~4~R           [@B126]; [@B62]; [@B108]; [@B28]; [@B52]; [@B50]; [@B37]; [@B144]; [@B145]
                                                                 • Allows quantitative analysis of S-PALM proteins\                                  •Requires multiple reactions and purification of samples, which can cause substantial sample loss\                                                                                                                                                                 
                                                                 • Both individual proteins and total protein extracts can be analyzed               •Incomplete blockade of free Cys residues can result in false positives\                                                                                                                                                                                           
                                                                                                                                                     •Indirect method\                                                                                                                                                                                                                                                  
                                                                                                                                                     • Insufficient hydrolysis of thioester by hydroxylamine or inefficient biotin labeling may generate false negatives                                                                                                                                                

                                                                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                        

  *Palmitoyl Protein Identification and Site Characterization*   • Provides large-scale profiling of protein S-PALM\                                 •Requires multiple reactions and purification of samples, which can cause substantial sample loss\                    PSD-95, SNAP 25, NOS, Fasn, PLP, NMDA, glutamate receptor, AMPA, Ddah1, Gja1, AP2A2, ADAM10, AP2, or Ahna                                    [@B138]; [@B19]
                                                                 • Allows quantitative analysis of modified proteins\                                •Incomplete blockade of free Cys residues can result in false positives\                                                                                                                                                                                           
                                                                 • Both single proteins and total protein extracts can be analyzed\                  •Indirect method\                                                                                                                                                                                                                                                  
                                                                 • Allows identification and S-PALM site characterization                            • Insufficient thioester hydrolysis by hydroxylamine or inefficient biotin labeling may generate false negatives                                                                                                                                                   

                                                                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                        

  *Resin-assisted capture of S-acylated proteins*                • Provides large-scale profiling of protein S-PALM\                                 •Requires multiple reactions and purification of samples, which can cause substantial sample loss\                    Gα~s~, Gα~11,~ H-ras, Uba1, SNAP23, Sec61b                                                                                                   [@B32], [@B31]
                                                                 • Allows quantitative analysis of modified proteins\                                •Incomplete blockade of free Cys residues can result in false positives\                                                                                                                                                                                           
                                                                 •Allows for S-PALM site identification                                              •Indirect method                                                                                                                                                                                                                                                   

                                                                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                        

  *Acyl-PEG exchange*                                            • Allows visualization of single S-PALM protein\                                    •Requires multiple reactions and purification of samples, which can cause substantial sample loss\                    IFITM3,                                                                                                                                      [@B96], [@B97]
                                                                 • Allows visualization of a number of S-PALM sites                                  •Incomplete blockade of free Cys residues can result in false positives\                                                                                                                                                                                           
                                                                                                                                                     •Indirect method                                                                                                                                                                                                                                                   

                                                                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                        
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Concluding Remarks
==================

*S*-palmitoylation is a frequent lipid modification that targets proteins to specific membrane compartments and has crucial regulatory functions. Over the last decade, significant progress has been made in the development of methods for the analysis of protein acylation. These new proteomic approaches provide insights into the importance of S-PALM to nerve cell function. This modification plays an important role in neuronal development and regulates the synaptic targeting of many proteins, thereby enabling efficient synaptic transmission. Accumulating evidence indicates that defects in palmitoylation are associated with a wide range of brain abnormalities, ranging from mental retardation to neurological disorders. Despite the methodological and technical advances that are discussed in this review, new strategies and analytical improvements are still needed to address existing limitations and challenges. For example, new methods are still needed to monitor dynamic S-PALM and explain its role in both normal physiology and disease. New label-free methods are also necessary to investigate palmitoylation *in vivo* in cells or tissues. This will certainly contribute to further advances in our knowledge and understanding of the complex mechanisms of functional synaptic modulation.
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